Similar articles for PMID: 2505565

Year	Number of Results
1987	4
1988	5
1989	3
1990	13
1991	11
1992	10
1993	9
1994	13
1995	11
1996	10
1997	13
2013	1
2017	1
2018	1
2019	3
2020	1
2023	0

1

Pruritus and paresthesia after i.v. administration of Gd-DTPA.

Chan K, Bosanko CM, Wang AM. Chan K, et al. AJNR Am J Neuroradiol. 1989 Sep-Oct;10(5 Suppl):S53. AJNR Am J Neuroradiol. 1989. PMID: 2505565 Free PMC article. No abstract available.

2

Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA. Results of a randomized, controlled clinical trial.

Niendorf HP, Haustein J, Louton T, Beck W, Laniado M. Niendorf HP, et al. Invest Radiol. 1991 Nov;26 Suppl 1:S221-3; discussion S232-5. doi: 10.1097/00004424-199111001-00075. Invest Radiol. 1991. PMID: 1808134 Clinical Trial. No abstract available.

3

[Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].

Campos A, Aznar L, Alamar R, Castelló JV. Campos A, et al. Med Clin (Barc). 1996 Feb 10;106(5):197. Med Clin (Barc). 1996. PMID: 8684023 Spanish. No abstract available.

4

Potential neurotoxic effects of gadopentetate dimeglumine: clinical significance.

Alhassan A, Weinmann HJ. Alhassan A, et al. AJNR Am J Neuroradiol. 1997 Apr;18(4):785-6; author reply 786-8. AJNR Am J Neuroradiol. 1997. PMID: 9127052 Free PMC article. No abstract available.

5

Anaphylactoid reactions to i.v. gadopentetate dimeglumine.

Tishler S, Hoffman JC Jr. Tishler S, et al. AJNR Am J Neuroradiol. 1990 Nov-Dec;11(6):1167; discussion 1168-9. AJNR Am J Neuroradiol. 1990. PMID: 2124049 Free PMC article. No abstract available.

6

[Artificial contrasting during magnetic resonance tomography].

Sergeev PV, Panov OV, Egorova SV, Bolotova EN, Shimanovskii NL, Akhadov TA, Sviridov NK. Sergeev PV, et al. Vestn Rentgenol Radiol. 1997 Jan-Feb;(1):45-52. Vestn Rentgenol Radiol. 1997. PMID: 9133071 Review. Russian. No abstract available.

7

[Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA].

Claussen C, Kornmesser W, Laniado M, Kaminsky S, Hamm B, Felix R. Claussen C, et al. Rofo. 1988 Jun;148(6):683-9. doi: 10.1055/s-2008-1048272. Rofo. 1988. PMID: 2837806 Clinical Trial. German.

8

Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine.

Witte RJ, Anzai LL. Witte RJ, et al. AJNR Am J Neuroradiol. 1994 Mar;15(3):523-4. AJNR Am J Neuroradiol. 1994. PMID: 8197951 Free PMC article.

9

Acute deterioration of myasthenia gravis after intravenous administration of gadolinium-DTPA.

Nordenbo AM, Somnier FE. Nordenbo AM, et al. Lancet. 1992 Nov 7;340(8828):1168. doi: 10.1016/0140-6736(92)93203-y. Lancet. 1992. PMID: 1359250 No abstract available.

10

[Gadolinium-DTPA (Magnevist) as contrast medium for arterial DSA].

Schild HH, Weber W, Boeck E, Mildenberger P, Strunk H, Düber C, Grebe P, Schadmand-Fischer S, Thelen M. Schild HH, et al. Rofo. 1994 Mar;160(3):218-21. doi: 10.1055/s-2008-1032410. Rofo. 1994. PMID: 8136474 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

107 results

Results by year